| Type | Description |
|---|---|
| Definition | BH3-like motif containing, cell death inducer |
| Date | Results | Publications |
|---|---|---|
| 2020-06-13 10:24:00 | MiR-501 knockdown or BH3-like motif-containing protein, cell death inducer (BLID) overexpression could reverse the effects of ADR Exo on recipient cells. | 31173853 |
| 2015-05-23 11:25:00 | Results showed that the expression of BLID is frequently downregulated in non-small cell lung tumors and cell lines and inversely correlates with miR-575 expression. | 25728273 |
| 2014-08-23 10:34:00 | loss of BLID may contribute to the progression of intraductal proliferation lesions to breast cancer. | 24532431 |
| 2013-12-14 10:05:00 | BRCC2 functions as a novel tumor suppressor in breast cancer and may be a potential therapeutic target for breast cancer management. | 23928696 |
| 2011-11-12 10:55:00 | Frequent loss of the BLID gene is observed in early-onset breast cancer. | 21846966 |
| Type | IDs |
|---|---|
| Synonymous | BRCC2 |
| Gene |
UniProtKB-ID:
BLID_HUMAN
UniprotKB:
Q8IZY5
UniParc:
UPI0000161930
EMBL:
AF303179,
BC130361,
BC130363
Ensembl:
ENSG00000259571
KO:
hsa:414899
|
| Nucleutide sequences |
EMBL-CDS:
AAN31127.1,
AAI30364.1,
AAI30362.1
Ensembl_TRS:
ENST00000560104
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000453153
RefSeq:
NP_001001786.2
|
| Others |
UniRef100:
UniRef100_Q8IZY5
UniRef90:
UniRef90_Q8IZY5
UniRef50:
UniRef50_Q8IZY5
UniGene:
Hs.686109
CCDS:
CCDS31693.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员